Table 1.
Clinicopathologic characteristics of patients with gastric adenocarcinoma.
| Training set (n = 13) | Test set for TSR assessment (n = 358) | |
|---|---|---|
| (Mean ± SD) | (Mean ± SD) | |
| Age | 53 (± 11.71) | 64 (± 12.88) |
| Sex | ||
| Male | 10 (76.92%) | 230 (64.25%) |
| Female | 3 (23.08%) | 128 (35.75%) |
| Lauren type | ||
| Intestinal | 7 (53.85%) | 76 (21.23%) |
| Diffuse | 6 (46.15%) | 225 (71.23%) |
| Mixed | 0 (0.00%) | 0 (0.00%) |
| Indeterminate | 0 (0.00%) | 27 (7.54%) |
| Pathology | ||
| Hepatoid adenocarcinoma | 0 (0.00%) | 1 (0.28%) |
| Mucinous adenocarcinoma | 0 (0.00%) | 27 (7.54%) |
| Signet-ring cell carcinoma | 1 (7.69%) | 36 (10.06%) |
| Tubular adenocarcinoma, well/moderately differentiated | 7 (53.85%) | 76 (21.23%) |
| Tubular adenocarcinoma, poorly differentiated | 5 (38.46%) | 218 (60.89%) |
| AJCC stage | ||
| Stage III | 7 (53.85%) | 163 (45.53%) |
| Stage IV | 6 (46.15%) | 195 (54.47%) |
SD standard deviation.